Journal list menu
Export Citations
Download PDFs
Thoracic Cancer
Age exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapy
- First Published: 26 June 2018
Challenges and research opportunities for lung cancer screening in China
- First Published: 07 June 2018
NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc
- First Published: 05 June 2018
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study
- First Published: 22 May 2018
Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance
- First Published: 09 May 2018
Aldolase A promotes proliferation and G1/S transition via the EGFR/MAPK pathway in non-small cell lung cancer
- First Published: 08 May 2018
Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis
- First Published: 27 April 2018
Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma
- First Published: 09 April 2018
Selection of candidates for surgery as local therapy among early-stage small cell lung cancer patients: a population-based analysis
- First Published: 31 March 2018
Gastric cancer: current and evolving treatment landscape
- First Published: 31 August 2016
Other Thoracic Cancer articles
In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
Liling Zhu, Shunrong Li, Luyuan Tan, Xiaolan Zhang, Jiannan Wu, Fengxi Su, Kai Chen, Erwei Song
Published: 04 December 2019
The immune landscape of esophageal cancer
Tu-Xiong Huang, Li Fu
Published: 26 November 2019
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone, Kazuo Kasahara
Published: 21 November 2019
The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)
Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao
Published: 07 November 2019
Sign up for email alerts
Tools
More from this journal
Cancer collection based on different tumor types
Information for Authors
Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.
Impact Factors in Journal Citation Report (2018, Clarivate) are under the previous journal title Chinese Journal of Cancer.
Archival Content
To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.
Understanding Open Access
As an open access journal, all articles in Cancer Communications are freely available to read, download and share immediately on publication.
Relevant Open – Access Health Sciences journals
Aging AND Cancer (2020-Present)
Cancer Innovation (2022-Present)
Clinical and Translational Medicine (2012-Present)
MedComm (2020-Present)
MedComm – Oncology (2022-Present)